DEALS BOOM IN OFF-PATENT AG CHEMICALS

被引：0
|
作者：
Reisch, Marc
机构：
来源：
CHEMICAL & ENGINEERING NEWS | 2014年 / 92卷 / 43期
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
下载
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [41] A Case Study of Pharmaceutical Pricing in China: Setting the Price for Off-Patent Originators
    Hu, Shanlian
    Zhang, Yabing
    He, Jiangjiang
    Du, Lixia
    Xu, Mingfei
    Xie, Chunyan
    Peng, Ying
    Wang, Linan
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2015, 13 (01) : S13 - S20
  • [42] Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study
    Yannick Vandenplas
    Steven Simoens
    Philippe Van Wilder
    Arnold G. Vulto
    Florian Turk
    Isabelle Huys
    BMC Health Services Research, 22
  • [43] TENDER APPROACHES IN THE OFF-PATENT BIOLOGICAL MEDICINES MARKET: A EUROPEAN COMPARATIVE ANALYSIS
    Barbier, L.
    Soontjens, C.
    Simoens, S.
    Vulto, A.
    Huys, I
    VALUE IN HEALTH, 2019, 22 : S424 - S424
  • [44] Generic but Expensive: Why Prices Can Remain High for Off-Patent Drugs
    Tessema, Frazer A.
    Kesselheim, Aaron S.
    Sinha, Michael S.
    HASTINGS LAW JOURNAL, 2020, 71 (04) : 1019 - 1052
  • [45] Market diffusion of biosimilars in off-patent biologic drug markets across Europe
    Boehm, Anna-Katharina
    Steiner, Isa Maria
    Stargardt, Tom
    HEALTH POLICY, 2023, 132
  • [46] A Case Study of Pharmaceutical Pricing in China: Setting the Price for Off-Patent Originators
    Shanlian Hu
    Yabing Zhang
    Jiangjiang He
    Lixia Du
    Mingfei Xu
    Chunyan Xie
    Ying Peng
    Linan Wang
    Applied Health Economics and Health Policy, 2015, 13 : 13 - 20
  • [47] How to realize the potential of off-patent biologicals and biosimilars in Europe? Guidance to policymakers
    Simoens, Steven
    Le Pen, Claude
    Boone, Niels
    Breedveld, Ferdinand
    Celano, Antonella
    Llombart-Cussac, Antonio
    Jorgensen, Frank
    Sule, Andras
    van Bodegraven, Ad A.
    Westhovens, Rene
    De Cock, Jo
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2018, 7 (02): : 70 - 74
  • [48] TENDERING OF OFF-PATENT BIOLOGICALS AND BIOSIMILARS: A PROPOSAL TOWARDS MORE SUSTAINABLE PRACTICES
    Barbier, L.
    Simoens, S.
    Vulto, A.
    Huys, I
    VALUE IN HEALTH, 2020, 23 : S417 - S417
  • [49] Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study
    Vandenplas, Yannick
    Simoens, Steven
    Van Wilder, Philippe
    Vulto, Arnold G.
    Turk, Florian
    Huys, Isabelle
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [50] Off-Patent Transgenic Events: Challenges and Opportunities for New Actors and Markets in Agriculture
    Rudelsheim, Patrick
    Dumont, Philippe
    Freyssinet, Georges
    Pertry, Ine
    Heijde, Marc
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2018, 6
12345